Evidence map›Paper›PMID 33392836›Full record

ArticleBreast cancer research and treatment2021

Association between VEGF single nucleotide polymorphism and breast cancer in the Northern China Han population.

Ziyao Li, Ying Wang, Cong Liu, Zhenzhen Wang, Dongmo Wang, Xingyu Liang, Jiawei Tian

Abstract read
PubMed Publisher
In one paragraph

Article in Breast cancer research and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. VEGFA gene variants are associated with breast cancer progression.The journal of pathology. Clinical research · 2024
    Article
  2. Article
  3. EJHaem · 2023
    Article
  4. Article
  5. Genes · 2022
    Article
  6. Study of the Association betweenJournal of personalized medicine · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ziyao LiDepartment of Ultrasound, Second Affiliated Hospital of Harbin Medical University, No 246 XueFu Road, Nan Gang Dist., Harbin, 150086, Heilongjiang Province, China.
Ying WangDepartment of General Surgery, Second Hospital of Hebei Medical University, Add: 215 Peace Road, Shijiazhuang, Hebei Province, China.
Cong LiuDepartment of Ultrasound, Second Affiliated Hospital of Harbin Medical University, No 246 XueFu Road, Nan Gang Dist., Harbin, 150086, Heilongjiang Province, China.
Zhenzhen WangDepartment of Ultrasound, Second Affiliated Hospital of Harbin Medical University, No 246 XueFu Road, Nan Gang Dist., Harbin, 150086, Heilongjiang Province, China.
Dongmo WangDepartment of Ultrasound, Second Affiliated Hospital of Harbin Medical University, No 246 XueFu Road, Nan Gang Dist., Harbin, 150086, Heilongjiang Province, China.
Xingyu LiangDepartment of Ultrasound, Second Affiliated Hospital of Harbin Medical University, No 246 XueFu Road, Nan Gang Dist., Harbin, 150086, Heilongjiang Province, China.
Jiawei TianDepartment of Ultrasound, Second Affiliated Hospital of Harbin Medical University, No 246 XueFu Road, Nan Gang Dist., Harbin, 150086, Heilongjiang Province, China. jiaweitian2016@163.com.ORCID http://orcid.org/0000-0002-2753-872X
Harbin Medical University · CNHebei Medical University · CN

Funding

NSFC 81271647NSFC 81630048
6 · The paper itself

Abstract

purposeTo investigate the associations of four commonly studied single nucleotide polymorphisms (SNP) of the vascular endothelial growth factor (VEGF), including -460T/C (rs833061), - 634G/C (rs2010963), - 2578C/A (rs699947), and +936T/C (rs3025039), with the incidence, aggressiveness, and tumor markers expression of breast cancer in the Northern China Han population.

methodsFollowed the genomic DNA extraction, a total of 259 patients with breast cancer (case group) and 273 healthy women (control group) underwent genotyping by PCR-LDR SNP assays. The associations between VEGF gene polymorphisms and the incidence, aggressiveness, and tumor markers expression of breast cancer were analyzed.

resultsSignificant differences were observed in allele frequency and genotype distribution of - 634G/C between breast cancer cases and healthy controls (p = 0.006, 0.013). Individuals who carry the G allele more likely had a lower risk of breast cancer (OR, 0.866, 95% CI 0.782-0.959). Compared with CC genotype carriers, women who had the CG and GG genotypes demonstrated a relatively lower risk (OR, 0.860, 95% CI 0.757-0.978, p = 0.022; OR, 0.778, 95% CI, 0.656-0.924, p = 0.004, respectively). When we stratified the group of patients according to the status of tumor markers, a significant association of - 634G/C SNP and Ki-67 expression was observed. The CC genotype carriers were more likely to be characterized by high expression of Ki-67 (p = 0.031). Further analysis showed that the - 460T/-634C/-2578C/+936C haplotype was more associated with a higher risk of breast cancer (OR, 1.445, 95% CI 1.123-1.859, p = 0.004), whereas the - 460T/- 634G/- 2578C/+936C one was associated with a lower risk (OR, 0.736, 95% CI 0.563-0.963, p = 0.025).

conclusionsIn the present study, we concluded that VEGF gene - 634G/C polymorphism is related to the incidence of breast cancer in the Han population in Northern China and also might be associated with tumor proliferation index Ki-67.

Indexed as

Breast NeoplasmsPolymorphism, Single NucleotideCase-Control StudiesChinaFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansVascular Endothelial Growth Factor AVascular Endothelial Growth Factor AVEGFA protein, humanBreast cancerKi-67Single nucleotide polymorphismVascular endothelial growth factor

Identifiers

PMID33392836
OpenAlexW3118523571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.